SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-051126
Filing Date
2023-10-02
Accepted
2023-10-02 17:01:20
Documents
2
Period of Report
2023-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1614
2 POA DOCUMENT poa.txt EX-24 3427
  Complete submission text file 0001209191-23-051126.txt   6422
Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address
George Dan (Reporting) CIK: 0001840534 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40388 | Film No.: 231300496